Personalized medicine

New approaches to drug dosing and consumption are resulting from a better understanding of the molecular mechanisms of the human body and have rapidly developed in recent decades. A population-based approach of "one tablet, three times a day" is becoming a thing of the past. New knowledge about the effects of active substances opens up new pharmacokinetic possibilities for the handling of medicines.

Clinical validation

Clinically validated vancomycin is one of the most common intravenous antibiotics. Approximately 10% of the global population has vancomycin as one of the first options for substituting penicillin antibiotics for those with allergy to penicillin. The drug-service-portfolio will also include low-molecular-weight heparin, cyxloporine and valproic acid, which operate on the principles of Therapeutic Drug Monitoring (TDM).

Cross-device

We integrate the results of research and technological development into the software core and algorithm being developed. We interface payment solutions and a user interface that enables online sales with the core. We are creating smart device versions for Android and iOS.